Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.

Muñoz G, de Gracia J, Buxó M, Alvarez A, Vendrell M.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701926. doi: 10.1183/13993003.01926-2017. Print 2018 Jan.

PMID:
29326318
2.

Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):79-87. doi: 10.1016/j.arbres.2017.07.015. Epub 2017 Nov 9. English, Spanish.

3.

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):88-98. doi: 10.1016/j.arbres.2017.07.016. Epub 2017 Nov 9. English, Spanish.

4.

Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.

López-Causapé C, de Dios-Caballero J, Cobo M, Escribano A, Asensio Ó, Oliver A, Del Campo R, Cantón R, Solé A, Cortell I, Asensio O, García G, Martínez MT, Cols M, Salcedo A, Vázquez C, Baranda F, Girón R, Quintana E, Delgado I, de Miguel MÁ, García M, Oliva C, Prados MC, Barrio MI, Pastor MD, Olveira C, de Gracia J, Álvarez A, Escribano A, Castillo S, Figuerola J, Togores B, Oliver A, López C, de Dios Caballero J, Tato M, Máiz L, Suárez L, Cantón R.

Int J Antimicrob Agents. 2017 Sep;50(3):334-341. doi: 10.1016/j.ijantimicag.2017.03.034. Epub 2017 Jul 20.

PMID:
28735882
5.

Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.

De la Rosa D, Martínez-Garcia MA, Giron RM, Vendrell M, Olveira C, Borderias L, Maiz L, Torres A, Martinez-Moragon E, Rajas O, Casas F, Cordovilla R, de Gracia J.

PLoS One. 2017 May 18;12(5):e0177931. doi: 10.1371/journal.pone.0177931. eCollection 2017.

6.

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.

Martinez-Garcia MA, Athanazio RA, Girón R, Máiz-Carro L, de la Rosa D, Olveira C, de Gracia J, Vendrell M, Prados-Sánchez C, Gramblicka G, Corso Pereira M, Lundgren FL, Fernandes De Figueiredo M, Arancibia F, Rached SZ.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.

7.

Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.

Olveira C, Padilla A, Martínez-García MÁ, de la Rosa D, Girón RM, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Casas F, Cordovilla R, de Gracia J.

Arch Bronconeumol. 2017 Jul;53(7):366-374. doi: 10.1016/j.arbres.2016.12.003. Epub 2017 Jan 21. English, Spanish.

8.

Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.

Cruz MJ, Curull V, Pijuan L, Álvarez-Simón D, Sánchez-Font A, de Gracia J, Culebras M, Ferrer J.

Arch Bronconeumol. 2017 Jun;53(6):318-323. doi: 10.1016/j.arbres.2016.08.016. Epub 2016 Nov 30. English, Spanish.

9.

Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective.

Jansen A, van Deuren M, Miller J, Litzman J, de Gracia J, Sáenz-Cuesta M, Szaflarska A, Martelius T, Takiguchi Y, Patel S, Misbah S, Simon A; Good syndrome Study Group.

Clin Immunol. 2016 Oct;171:12-17. doi: 10.1016/j.clim.2016.07.025. Epub 2016 Aug 4.

10.

The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.

Martínez-García MÁ, Vendrell M, Girón R, Máiz-Carro L, de la Rosa Carrillo D, de Gracia J, Olveira C.

Ann Am Thorac Soc. 2016 Sep;13(9):1468-75. doi: 10.1513/AnnalsATS.201510-678OC.

PMID:
27348199
11.

Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.

Sánchez-Ramón S, de Gracia J, García-Alonso AM, Rodríguez Molina JJ, Melero J, de Andrés A, García Ruiz de Morales JM, Ferreira A, Ocejo-Vinyals JG, Cid JJ, García Martínez JM, Lasheras T, Vargas ML, Gil-Herrera J, García Rodríguez MC, Castañer JL, González Granado LI, Allende LM, Soler-Palacin P, Herráiz L, López Hoyos M, Bellón JM, Silva G, Gurbindo DM, Carbone J, Rodríguez-Sáinz C, Matamoros N, Parker AR, Fernández-Cruz E; EMPATHY group.

Clin Immunol. 2016 Aug;169:80-84. doi: 10.1016/j.clim.2016.05.006. Epub 2016 May 25. No abstract available.

12.

Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis.

Muñoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R, Polverino E, Alvarez A, Birring SS, Vendrell M.

Chron Respir Dis. 2016 May;13(2):128-36. doi: 10.1177/1479972316632005. Epub 2016 Feb 22.

13.

Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.

de Dios Caballero J, Pastor MD, Vindel A, Máiz L, Yagüe G, Salvador C, Cobo M, Morosini MI, del Campo R, Cantón R; GEIFQ Study Group.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1878-82. doi: 10.1128/AAC.02067-15.

14.

Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study.

de Dios Caballero J, Del Campo R, Royuela A, Solé A, Máiz L, Olveira C, Quintana-Gallego E, de Gracia J, Cobo M, de la Pedrosa EG, Oliver A, Cantón R; GEIFQ (Grupo Español para el Estudio de la Colonización/Infección Broncopulmonar en Fibrosis Quística).

J Cyst Fibros. 2016 May;15(3):357-65. doi: 10.1016/j.jcf.2015.09.004. Epub 2015 Sep 28.

PMID:
26429520
15.

Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.

Vendrell M, Muñoz G, de Gracia J.

Open Respir Med J. 2015 Mar 31;9:30-6. doi: 10.2174/1874306401509010030. eCollection 2015.

16.

Bronchiectasis: a retrospective study of clinical and aetiological investigation in a general respiratory department.

Amorim A, Bento J, Vaz AP, Gomes I, de Gracia J, Hespanhol V, Marques A.

Rev Port Pneumol (2006). 2015 Jan-Feb;21(1):5-10. doi: 10.1016/j.rppnen.2014.06.009. Epub 2015 Jan 22.

17.

Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice.

Justicia JL, Solé A, Quintana-Gallego E, Gartner S, de Gracia J, Prados C, Máiz L.

Expert Rev Respir Med. 2015 Apr;9(2):183-94. doi: 10.1586/17476348.2015.1016504. Epub 2015 Feb 18. Review.

PMID:
25692532
18.

Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.

Cantón R, Máiz L, Escribano A, Olveira C, Oliver A, Asensio O, Gartner S, Roma E, Quintana-Gallego E, Salcedo A, Girón R, Barrio MI, Pastor MD, Prados C, Martínez-Martínez MT, Barberán J, Castón JJ, Martínez-Martínez L, Poveda JL, Vázquez C, de Gracia J, Solé A; en representación del Grupo Español de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Quística.

Arch Bronconeumol. 2015 Mar;51(3):140-50. doi: 10.1016/j.arbres.2014.09.021. Epub 2015 Jan 20. English, Spanish.

19.

Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa.

Sole A, Poveda JL, Giron RM, Prados MC, De GJ, Casado MÁ.

Value Health. 2014 Nov;17(7):A526. doi: 10.1016/j.jval.2014.08.1659. Epub 2014 Oct 26. No abstract available.

20.

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

Barker AF, O'Donnell AE, Flume P, Thompson PJ, Ruzi JD, de Gracia J, Boersma WG, De Soyza A, Shao L, Zhang J, Haas L, Lewis SA, Leitzinger S, Montgomery AB, McKevitt MT, Gossage D, Quittner AL, O'Riordan TG.

Lancet Respir Med. 2014 Sep;2(9):738-49. doi: 10.1016/S2213-2600(14)70165-1. Epub 2014 Aug 18.

PMID:
25154045
21.

Diagnostic of cystic fibrosis in adult.

de Gracia J, Alvarez Fernández A.

Rev Clin Esp. 2014 Aug-Sep;214(6):309-10. doi: 10.1016/j.rce.2014.05.012. Epub 2014 Jun 20. English, Spanish. No abstract available.

PMID:
24954292
22.

Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

Gathmann B, Mahlaoui N; CEREDIH, Gérard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW; Dutch WID, van Beem RT, Guzman D, Workman S, Soler-Palacín P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H, Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U, Meyts I, Kutukculer N, Wågström P, Galal NM, Roesler J, Farmaki E, Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S, Panahloo Z, Grimbacher B; European Society for Immunodeficiencies Registry Working Party.

J Allergy Clin Immunol. 2014 Jul;134(1):116-26. doi: 10.1016/j.jaci.2013.12.1077. Epub 2014 Feb 28.

PMID:
24582312
23.

Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.

Martínez-García MÁ, de Gracia J, Vendrell Relat M, Girón RM, Máiz Carro L, de la Rosa Carrillo D, Olveira C.

Eur Respir J. 2014 May;43(5):1357-67. doi: 10.1183/09031936.00026313. Epub 2013 Nov 14.

24.

Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.

Masvidal L, Igreja S, Ramos MD, Alvarez A, de Gracia J, Ramalho A, Amaral MD, Larriba S, Casals T.

Eur J Hum Genet. 2014 Jun;22(6):784-91. doi: 10.1038/ejhg.2013.238. Epub 2013 Oct 16.

25.

Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia.

de la Torre MC, Bolíbar I, Vendrell M, de Gracia J, Vendrell E, Rodrigo MJ, Boquet X, Torrebadella P, Yébenes JC, Serra-Prat M, Rello J, Torres A, Almirall J.

Respir Med. 2013 Dec;107(12):2038-45. doi: 10.1016/j.rmed.2013.09.005. Epub 2013 Sep 18.

26.

TACI mutation in Good's Syndrome: in search of a genetic basis.

Sáenz-Cuesta M, Martínez-Pomar N, de Gracia J, Echaniz P, Villegas E, Prada A, Otaegui D, Matamoros N, Cuadrado E.

Clin Immunol. 2012 Oct;145(1):27-30. doi: 10.1016/j.clim.2012.07.014. Epub 2012 Aug 4. No abstract available.

PMID:
22922270
27.

GUSB and ATP2B4 are suitable reference genes for CFTR gene expression data normalization in nasal epithelium cells.

Masvidal L, Alvarez A, Ruano L, de Gracia J, Larriba S, Casals T.

J Cyst Fibros. 2012 Sep;11(5):398-404. doi: 10.1016/j.jcf.2012.03.008. Epub 2012 Apr 22.

28.

Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.

Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B.

Clin Immunol. 2011 Oct;141(1):90-102. doi: 10.1016/j.clim.2011.06.002. Epub 2011 Jun 12.

29.

[Hard metal interstitial lung disease].

Montero MA, de Gracia J, Morell F.

Arch Bronconeumol. 2010 Sep;46(9):489-91. doi: 10.1016/j.arbres.2009.10.007. Epub 2009 Dec 4. Spanish.

30.

Role of TNFRSF13B variants in patients with common variable immunodeficiency.

Martínez-Pomar N, Detková D, Arostegui JI, Alvarez A, Soler-Palacín P, Vidaller A, Espanol T, Sampalo A, de Gracia J, Hernandez M, Yagüe J, Matamoros N.

Blood. 2009 Sep 24;114(13):2846-8. doi: 10.1182/blood-2009-05-213025. No abstract available.

31.

[Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery].

Vendrell M, de Gracia J, Olveira C, Martínez MA, Girón R, Máiz L, Cantón R, Coll R, Escribano A, Solé A.

Arch Bronconeumol. 2008 Nov;44(11):629-40. Spanish.

32.

Visual vignette. Malignant infantile osteopetrosis.

Pachón Burgos A, Farrugia de Castrellón J, De Gracia J.

Endocr Pract. 2008 Apr;14(3):394. No abstract available.

PMID:
18463053
33.

[Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease].

Morell F, Reyes L, Doménech G, De Gracia J, Majó J, Ferrer J.

Arch Bronconeumol. 2008 Apr;44(4):185-91. Spanish.

34.

Herpetic tracheitis and polybacterial pneumonia in an immunocompetent young man is herpes tracheitis involved in the pathogenesis of bacterial pneumonia?

Alvarez-Uria G, Surinach JM, Ventura A, de la Rosa D, de Gracia J, Fernandez-Sevilla T.

J Clin Virol. 2008 Feb;41(2):164-5. Epub 2007 Nov 28.

PMID:
18054276
35.

Common variable immunodeficiency: association between memory B cells and lung diseases.

Detková D, de Gracia J, Lopes-da-Silva S, Vendrell M, Alvarez A, Guarner L, Vidaller A, Rodrigo MJ, Caragol I, Espanol T, Hernández M.

Chest. 2007 Jun;131(6):1883-9. Epub 2007 Mar 30.

PMID:
17400689
36.

Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation.

De Gracia J, Culebras M, Alvarez A, Catalán E, De la Rosa D, Maestre J, Canela M, Román A.

Respir Med. 2007 Jan;101(1):27-33. Epub 2006 Jun 13.

37.

Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR, de Gracia J, Matamoros N.

Clin Exp Immunol. 2006 May;144(2):233-8.

38.

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.

Clin Microbiol Infect. 2005 Sep;11(9):690-703. Review.

39.

A new BAL fluid instillation and aspiration technique: a multicenter randomized study.

Rosell A, Xaubet A, Agustí C, Castella J, Puzo C, Curull V, de Gracia J; RASTA study group.

Respir Med. 2006 Mar;100(3):529-35. Epub 2005 Jul 14.

40.

Antibody deficiency in bronchiectasis.

Miravitlles M, Vendrell M, de Gracia J.

Eur Respir J. 2005 Jul;26(1):178-80. No abstract available.

41.

Genotype-phenotype correlation for pulmonary function in cystic fibrosis.

de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.

Thorax. 2005 Jul;60(7):558-63.

42.

Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats.

Sáez-Valero J, de Gracia JA, Lockridge O.

Neurosci Lett. 2005 Jul 22-29;383(1-2):93-8. Epub 2005 Apr 12.

PMID:
15936518
43.

Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia.

Ibáñez C, Suñé P, Fierro A, Rodríguez S, López M, Alvarez A, De Gracia J, Montoro JB.

BioDrugs. 2005;19(1):59-65.

PMID:
15691218
44.

A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulin.

Matamoros N, De Gracia J, Hernández F, Pons J, Alvarez A, Jiménez V.

Int Immunopharmacol. 2005 Mar;5(3):619-26. Erratum in: Int Immunopharmacol. 2006 Mar;6(3):513.

PMID:
15683857
45.

Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology.

Vendrell M, de Gracia J, Rodrigo MJ, Cruz MJ, Alvarez A, Garcia M, Miravitlles M.

Chest. 2005 Jan;127(1):197-204. Erratum in: Chest. 2006 Jan;129(1):216.

PMID:
15653984
46.

Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?

Casals T, De-Gracia J, Gallego M, Dorca J, Rodríguez-Sanchón B, Ramos MD, Giménez J, Cisteró-Bahima A, Olveira C, Estivill X.

Clin Genet. 2004 Jun;65(6):490-5.

PMID:
15151509
47.

Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency.

de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, Mata F, Andreu J, Morell F.

Int Immunopharmacol. 2004 Jun;4(6):745-53.

PMID:
15135316
48.

Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysis.

de Gracia J, de la Rosa D, Catalán E, Alvarez A, Bravo C, Morell F.

Respir Med. 2003 Jul;97(7):790-5.

PMID:
12854628
49.

[Acute pancreatitis as a first manifestation of cystic fibrosis].

Ledesma S, Alvarez A, Torres M, de Gracia J.

Med Clin (Barc). 2003 Mar 22;120(10):399. Spanish. No abstract available.

PMID:
12681109
50.

[Cystic fibrosis in adults: study of 111 patients].

de Gracia J, Alvarez A, Mata F, Guarner L, Vendrell M, Gadtner S, Cobos N.

Med Clin (Barc). 2002 Nov 9;119(16):605-9. Spanish.

PMID:
12433335

Supplemental Content

Loading ...
Support Center